Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
"Disease modifying nutricals" for multiple sclerosis.
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
A web-based electronic neurology referral system: a solution for an overburdened healthcare system?
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Contribution of MicroRNAs to autoimmune diseases.
Teva targets $4 billion lupus market with laquinimod study
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design.
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture.
Evidence linking HHV-6 with multiple sclerosis: an update.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Pages
« first
‹ previous
…
217
218
219
220
221
222
223
224
225
…
next ›
last »